PPT-Paper Switch-off Programme

Initial engagement Sample please localise and update as necessary Grey font optional amp can be removed as per local preference Date 2 Contents 1 Target 2 Implications 3 Benefits. Green wire is not connected to ground Connect green wire to ground Ground is required for the sensor switch to function Models MSOPS2 MSVPS2 MSOPS5M MSVPS5M MSOPS6M2DV MSVPS6M2DV White wire is not connected to neutral Connect white wire to neutral N A and then SWITCH SIDESCCDC B Switch sides after points1,5,9,13,17, Recycling Programme in Office Buildings DO YOU KNOW ..... L ANGKAWI HARTER LIGHT NCENTIVE ROG programme durationThe LCFIP will be applicable for four (4) years effective from 01 January 2012 to 31 December 2015. 3 definitionsThe following definitions sh ou can temporarily switch your role Switch your role Note: Role Switch vs. Impersonate Updated: 8/18/14Page of LSCOnline Role Switch vs. Impersonate Figure 3The Role Switchwidget will reflect the the the Staggering Switch architecture shown two stages: scheduling stage and the switching stage. stage is a reconfigurably nonblocking switching fabric. These stages are with elec- tronically contro CYQ Level . 3 Standardisation . Training Day . To introduce centre staff to the methods of best practice in delivery and assessment of the Level 3 Certificate in Personal Training. Outcomes:. - Identify the structure of QCF Level 3 Certificate in Personal Training. STRIIVING . Study. Design. Endpoints. Primary: proportion of patients maintaining HIV RNA < 50 c/mL at W48 . (ITT-E, snapshot) ; non-inferiority if lower margin of the two-sided 95% CI . for the difference = - 10%, 90% power . SWORD. . Study. Switch to CAB LA RPV LA IM. LATTE-2 Study. . . LATTE-2 Study: switch to cabotegravir LA rilpivirine LA IM. Objective. Primary: % HIV RNA < 50 c/mL at W32 of maintenance phase: selection of dosing schedule for phase III studies (confirmation of dose on W48 analysis) ; safety. stop using your credit cards - switch to MOVO to spend just what you have budgeted for the month Endpoints. Primary: proportion of patients with HIV RNA ≥ 50 c/mL at W48 (ITT-E, snapshot) ; non-inferiority if upper margin of the two-sided 95% CI for the difference = 4%, 97.3% power . Secondary: proportion of patients with HIV RNA < 50 c/mL at W48 (ITT-E, snapshot) ; non-inferiority if lower margin of the two-sided 95% CI for the difference = - 8%. Switch to ATV/r-. containing. . regimen. ATAZIP. Switch to ATV ± r-containing . regimen. SWAN . Study. SLOAT . Study. Switch . to ATV-. containing. . regimen. ARIES . Study. INDUMA . Study. ASSURE . Canadian Study. CHEER. Montreal Study. EASIER. SWITCHMRK. SPIRAL. Switch ER. Design. Endpoints. Primary: non inferiority in the proportion of patients with treatment failure at W48* (non completer = failure, intent-to-treat analysis), lower . ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-TDF-FTC. ROCKET-1: Design. Source: Moyle GJ, et al. . PLoS. One. 2015;10:e0116297.. Immediate switch arm. EFV-TDF-FTC. . (n = 79). Delayed switch arm .